The estimated Net Worth of William Roberts is at least $46 Million dollars as of 18 September 2013. William Roberts owns over 15,000 units of Regeneron Pharmaceuticals stock worth over $40,685,844 and over the last 21 years William sold REGN stock worth over $5,270,640.
William has made over 19 trades of the Regeneron Pharmaceuticals stock since 2008, according to the Form 4 filled with the SEC. Most recently William exercised 15,000 units of REGN stock worth $252,000 on 18 September 2013.
The largest trade William's ever made was exercising 60,000 units of Regeneron Pharmaceuticals stock on 10 January 2012 worth over $1,267,200. On average, William trades about 10,152 units every 60 days since 2003. As of 18 September 2013 William still owns at least 35,644 units of Regeneron Pharmaceuticals stock.
You can see the complete history of William Roberts stock trades at the bottom of the page.
Over the last 22 years, insiders at Regeneron Pharmaceuticals have traded over $13,084,686,326 worth of Regeneron Pharmaceuticals stock and bought 8,562,481 units worth $2,539,854,760 . The most active insiders traders include Sanofi, Pharma Ag Novartis, and Leonard S Schleifer. On average, Regeneron Pharmaceuticals executives and independent directors trade stock every 8 days with the average trade being worth of $47,694,347. The most recent stock trade was executed by Marion Mc Court on 3 September 2024, trading 1,000 units of REGN stock currently worth $381,400.
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.
Regeneron Pharmaceuticals executives and other stock owners filed with the SEC include: